🔗 Visit the ClinicalTrials.gov page for NCT00559650
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. | Pharmacol Ther | 2009 | 1.66 |
| 2 | Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. | Eur Heart J | 2012 | 1.03 |
| 3 | Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase. | Br J Pharmacol | 2010 | 0.97 |
| 4 | Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. | Clin Pharmacol Ther | 2014 | 0.83 |